{"acute graft versus host disease": 49.92, "acute graft versus host disease in intestine": 146.06, "acute graft versus host disease in skin": 218.93, "anaemia": 4.17, "aplastic anaemia": 32.66, "cystitis haemorrhagic": 45.99, "cytomegalovirus infection reactivation": 81.41, "deafness": 10.75, "febrile neutropenia": 22.27, "focal nodular hyperplasia": 1379.47, "graft versus host disease in gastrointestinal tract": 160.51, "haematotoxicity": 30.24, "hepatotoxicity": 29.16, "leukopenia": 3.31, "mucosal inflammation": 83.41, "myelosuppression": 4.34, "nervous system disorder": 23.56, "neutropenia": 11.43, "off label use": 3.18, "platelet count decreased": 2.55, "product use in unapproved indication": 4.47, "sepsis": 5.24, "stomatitis": 4.71, "thrombocytopenia": 11.27, "venoocclusive liver disease": 65.7, "visual impairment": 3.81}